Preoperative Imaging in Retroperitoneal Sarcoma
PIRS
1 other identifier
observational
32
1 country
1
Brief Summary
This is a prospective observational study in which patients with untreated retroperitoneal sarcoma will have Magnetic Resonance Imaging (MRI) prior to surgery. In addition, patients who will be undergoing pre-operative radiotherapy will have an additional MRI scan at two weeks post radiotherapy. For both groups, the magnetic resonance images will be correlated with tumour pathology. The study hypothesis is that Magnetic Resonance Imaging will provide a more accurate assessment of tumour volume and local staging than CT and will identify areas of altered oxygenation, cellularity and perfusion which change in response to radiotherapy before tumour shrinkage occurs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 9, 2013
CompletedFirst Posted
Study publicly available on registry
July 18, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2017
CompletedAugust 8, 2018
August 1, 2018
4 years
July 9, 2013
August 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction, by MRI, of early response to radiotherapy prior to tumour shrinkage
Changes in volume, maximum axial diameter, ADC, F, D, D\*, T2, R2\* and enhancing fraction from baseline to post radiotherapy will be presented. A paired T-test (or Wilcoxon Signed Rank Test) may be used to test the difference between baseline and post radiotherapy. Differences in these values will be presented for responders and non-responders, which will be tested by independent T-test. Response will be determined by tumour size, enhancing fraction and histopathological evidence of response.
2-4 weeks
Secondary Outcomes (1)
To determine the reproducibility of multi-parametric MRI measurements within tumour regions of interest in patients with retroperitoneal sarcoma.
1-7 days
Other Outcomes (1)
Correlation of imaging features with histopathological assessment of tumour size, local staging, cellularity, necrosis and viable tumour.
2 months
Study Arms (2)
Curative intent surgery alone
Patients with retroperitoneal sarcoma randomised into surgery alone arm.
Pre-operative radiotherapy plus surgery
Patients with retroperitoneal sarcoma randomised to Arm 2: pre-operative radiotherapy plus surgery.
Interventions
Eligibility Criteria
Patients with retroperitoneal sarcoma randomised for preoperative radiotherapy plus surgery versus surgery alone.
You may qualify if:
- Patients with retroperitoneal sarcomas planned for surgical resection +/- preoperative radiotherapy.
You may not qualify if:
- MRI incompatible metal implants
- claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute of Cancer Research, United Kingdomlead
- Royal Marsden NHS Foundation Trustcollaborator
- Cancer Research UKcollaborator
Study Sites (1)
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, SM2 5PT, United Kingdom
Related Publications (1)
Winfield JM, Miah AB, Strauss D, Thway K, Collins DJ, deSouza NM, Leach MO, Morgan VA, Giles SL, Moskovic E, Hayes A, Smith M, Zaidi SH, Henderson D, Messiou C. Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With Histopathology. Front Oncol. 2019 Apr 25;9:280. doi: 10.3389/fonc.2019.00280. eCollection 2019.
PMID: 31106141DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Translational Imaging
Study Record Dates
First Submitted
July 9, 2013
First Posted
July 18, 2013
Study Start
July 1, 2013
Primary Completion
June 30, 2017
Study Completion
June 30, 2017
Last Updated
August 8, 2018
Record last verified: 2018-08